Description
This webinar will cover the latest application of molecular and genomic biomarker testing in solid tumors. Learners will gain a deeper understanding of how biomarker testing is being performed and how these results are informing personalized treatment plans for patients with solid tumors. The faculty will discuss ways to interpret and report test results so that oncologists are supported as they develop treatment plans for patients.
Release Date
February 27, 2025
12 pm to 1 pm Eastern Time
Faculty
Theresa Boyle, MD, PhD
Associate Member
Medical Director, Molecular Solid Tumor
Moffitt Cancer Center and Research Institute
Kimberly Newsom, PhD, HCLD(ABB), MB(ASCP)CM
Clinical Assistant Professor
Molecular Pathology Informatics
Department of Pathology, Immunology and Laboratory Medicine
UF Health Pathology Laboratories | University of Florida
Target Audience
This program is designed for pathologists.
Learning Objectives
At the conclusion of this activity, learners should be better able to:
• Explain the methodology and clinical utility of molecular and genomic testing in various solid tumors.
• Evaluate the interpretation and reporting of molecular biomarker test results.
• Apply genomic testing results to support personalized treatment plans and inform prognosis.
Support Statement
Support for this accredited continuing education activity has been made possible through educational grants from AstraZeneca and Daiichi Sankyo.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Florida Society of Pathologists (FSP). American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other members of the care team will receive a certificate of participation.
How to Participate in this Activity and Obtain CME Credit
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the program evaluation.
Disclosures
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Faculty/Planner:
Theresa Boyle, MD, PhD: Discloses the following relevant financial relationships:
Grant/Research Support: Bristol Myers Squibb
Speaker’s Bureau: Bristol Myers Squibb
Kimberly Newsom, PhD, HCLD(ABB), MB(ASCP)CM has no relevant financial relationships with ineligible companies to disclose.
Planners:
John JD Juchniewicz, MCIS, CHCP, FACEHP - American Academy of CME: No relevant financial relationships with ineligible companies to disclose.
Erin Corrales - Florida Society of Pathologists: No relevant financial relationships with ineligible companies to disclose.
Joseph Kim, MD – Florida Society of Pathologists: No relevant financial relationships with ineligible companies to disclose.
Marilyn Bui, MD, PhD – Florida Society of Pathologists: Discloses the following relevant financial relationships:
Advisory Board/Consultant: Visiopharm, Aiforia, Roche, AstraZeneca, PathAI, DigitCells, Merck.
Unlabeled and Investigational Usage
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or Florida Society of Pathologists. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information. This activity may contain discussion of unlabeled/investigational usage.
Privacy